Quantitative circulating tumor DNA (ctDNA) assessment in patients (pts) with advanced urothelial carcinoma (UC) treated with pembrolizumab (pembro) or platinum-based chemotherapy (chemo) from the ...
In designing and manufacturing therapeutic antibodies, a top objective is precise binding to an intended target. Sometimes, the antibodies can bind to each other through self-association. In a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback